A clinical trail to study the effects, safety and efficacy of Polyherbal formulations in patients with mild to moderate psoriasis

Clinical study of Psoriasis tablet and oil in Psoriasis

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2010/091/000594

Enrollment

Registered

2010-07-20

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Health intervention: dose 6 tab. and oil at affected area daily for 3 months Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: Sex: both male and female.Age 18-70.Newly diagnosed cases of psoriatic patients with mild to moderate psoriasis

Exclusion criteria

Exclusion criteria: Patients having evidence of extensive disease that require hospitalization and pregnant women.

Design outcomes

Primary

Measure	Time frame
The predefined primary end points were clinical and laboratory evidence to treat psoriasisTimepoint: measurement of PASI,Mean Score, Global assessment by physician and Global assessment by patient	—

Secondary

Measure	Time frame
To see the efficacy of Polyherbal formulations in PsoriasisTimepoint: In terms of sense of well being	—

Countries

India

Contacts

Public ContactDr. Amar V. Desai

Reg No GBI-13186

amarvdesai@gmail.com02637-258749

Outcome results